Wells Fargo’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,489
| Closed | -$32K | – | 7012 |
|
|
2024
Q1 | $32K | Buy |
13,489
+1,879
| +16% | +$4.45K | ﹤0.01% | 5045 |
|
|
2023
Q4 | $26.1K | Buy |
11,610
+2,292
| +25% | +$5.16K | ﹤0.01% | 5109 |
|
|
2023
Q3 | $19.8K | Sell |
9,318
-5,001
| -35% | -$10.6K | ﹤0.01% | 5239 |
|
|
2023
Q2 | $44.2K | Buy |
14,319
+14,097
| +6,350% | +$43.6K | ﹤0.01% | 5184 |
|
|
2023
Q1 | $1.19K | Buy |
222
+106
| +91% | +$570 | ﹤0.01% | 6009 |
|
|
2022
Q4 | $771 | Buy |
116
+6
| +5% | +$40 | ﹤0.01% | 5942 |
|
|
2022
Q3 | $0 | Buy |
110
+40
| +57% | – | ﹤0.01% | 7112 |
|
|
2022
Q2 | $0 | Sell |
70
-355
| -84% | – | ﹤0.01% | 7232 |
|
|
2022
Q1 | $3K | Sell |
425
-6,744
| -94% | -$47.6K | ﹤0.01% | 6251 |
|
|
2021
Q4 | $83K | Buy |
7,169
+7,139
| +23,797% | +$82.7K | ﹤0.01% | 5318 |
|
|
2021
Q3 | $0 | Sell |
30
-59
| -66% | – | ﹤0.01% | 7196 |
|
|
2021
Q2 | $2K | Sell |
89
-3,470
| -97% | -$78K | ﹤0.01% | 6226 |
|
|
2021
Q1 | $153K | Buy |
+3,559
| New | +$153K | ﹤0.01% | 4964 |
|